Calvin Scott Recalls Phendimetrazine Tablets Due to Packaging Defects
Calvin Scott & Company is recalling specific lots of Phendimetrazine 35mg tablets because they were repackaged in transparent pouches, violating CGMP requirements for light-sensitive drugs.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a CGMP deviation regarding packaging for light-sensitive drugs, which fits the criteria for moderate severity involving minor labeling or packaging errors without reported illness.
Plain-English summary
Calvin Scott & Company, Inc. is voluntarily recalling specific lots of Phendimetrazine Yellow Tabs 35mg, 28-count bags. The recall is due to Current Good Manufacturing Practice (CGMP) deviations where light-sensitive drug products were repackaged in transparent or partially transparent pouches.
The affected product is distributed nationwide within the United States. Specific lot numbers and expiration dates are listed in the recall documentation, including lots 19185, 19220, 19256, 19334, 20001, and 20046.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or the recalling firm for instructions on return or replacement.
The recalled product
- Product
- Phendimetrazine Yellow Tabs 35mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech, Newtown, PA 18940, NDC 0702-0077-10
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: 19185
- 19220
- Exp. Date: 08/20
- 19256
- Exp. Date: 09/20
- 19334
- Exp. Date: 12/20
- 20001
- Exp. Date: 01/21: 20046
- Exp. Date: 2/21
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12